Navigation Links
Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
Date:11/14/2007

blic offering, assumed the position of Senior Vice President of Finance and Information Systems in 2002, and was promoted to Chief Financial Officer in October 2006. Before joining Digene, Mr. Slattery served as an audit manager at KPMG and as a staff auditor at Ernst & Young. He holds a B.S. degree in accounting from Bentley College and is a certified public accountant.

The Company and Mr. Schneider anticipate that Mr. Schneider will enter into a consulting agreement with the Company pursuant to which he will assist the Company in ensuring an efficient transition of the audit committee chair responsibilities to Mr. Slattery.

About Micromet, Inc. (http://www.micromet-inc.com)

Micromet, Inc. is a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Three of its antibodies are in clinical development. MT103 (MEDI-538), the first antibody in Micromet's product pipeline developed utilizing the BiTE(R) antibody technology platform, is being evaluated in a phase 2 clinical trial for the treatment of patients with acute lymphoblastic leukemia, and in a phase 1 clinical trial for the treatment of patients with non-Hodgkin's lymphoma. BiTE antibodies represent a new class of antibodies that activate a patient's own cytotoxic T cells to eliminate cancer cells. Micromet is developing MT103 in collaboration with MedImmune, a subsidiary of Astra Zeneca plc. The second clinical stage antibody is adecatumumab (MT201), a human monoclonal antibody targeting EpCAM expressing tumors. Adecatumumab is being developed by Micromet in collaboration with Merck Serono in a phase 1b clinical trial evaluating adecatumumab in combination with docetaxel for the treatment of patients with metastatic breast cancer. The third clinical stage antibody is MT293 (formerly D93), also known as TRC093, a first-in-class humanized monoclonal antibody that
'/>"/>

SOURCE Micromet, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. KGI Elects Three New Members to Board of Trustees
3. The Pittsburgh Life Sciences Greenhouse Elects Four New Members to Its Board of Directors
4. Genaera Elects New Board Member and Announces Executive Appointments
5. MedAssets Supply Chain Systems Selects Siemens Medical Solutions Diagnostics for Chemistry, Automation and Immunoassay Solutions
6. Amylin Pharmaceuticals Elects Adrian Adams to Board of Directors
7. Detroit Department of Health and Wellness Promotion Selects Netsmart Technologies Public Health Software
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
10. DOV Pharmaceutical, Inc. Begins Trading on OTC Bulletin Board
11. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... Ontario (PRWEB) November 27, 2014 Spartan ... Ministry of Food and Drug Safety (MFDS) regulatory approval ... system provides genetic results in less than 60 minutes ... is indicated as an aid for doctors to determine ... genetic pathway. These include some of the world’s most ...
(Date:11/27/2014)... EDINBURGH , November 27, 2014 ... on revolutionising the management of tooth decay, today ... study of its Calcivis® Caries Activity Imaging System. ... is a sophisticated medical device and consumable combination ... dental caries (tooth decay). It involves a unique, ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Publicis Healthcare ... today announced the organization has won a total of ... Digitas Health LifeBrands was honored with a Silver Award ... agencies received eight Awards of Excellence. , The ... pharmaceutical advertising and promotion. The Awards provide a forum ...
(Date:11/26/2014)... 2014 Deep Research Report on ... in-depth research report on the Ammonium Bifluoride market, ... classification, application, and industry chain structure as well ... market analysis, including China’s domestic market as well ... China, Japan etc. regions) industry analysis covering macroeconomic ...
Breaking Biology Technology:Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 2Spartan Bioscience Receives Korean Regulatory Approval for First Rapid DNA Test of Mutations Affecting Metabolism of Common Drugs 3Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 2Calcivis Completes Clinical Study of Novel Caries Activity Imaging System 3Publicis Healthcare Wins 20 Rx Club Awards 2Publicis Healthcare Wins 20 Rx Club Awards 3Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 2Ammonium Bifluoride Market International Analysis of Manufacturing, Technology & Trends Now at ReportsnReports.com 3
... , REDWOOD CITY, Calif. , June 17 ... today announced a global strategic alliance to discover, develop and commercialize ... stem cells are a subset of tumor cells believed to play ...   , , , ...
... at Rensselaer Polytechnic Institute have developed a new, ... measure only billionths of a meter thick. The ... on nearly any surface including silicon wafers, could ... Sang-Kee Eah, assistant professor in the Department ...
... ... ability to study the functional relevance of a drug treatment on the heart following ... , ... 2010 -- MD Biosciences , a Preclinical Contract Research Organization (CRO), offers in ...
Cached Biology Technology:OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics 2OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics 3OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics 4OncoMed Pharmaceuticals and Bayer Schering Pharma Announce Strategic Alliance to Develop Anti-Cancer Stem Cell Therapeutics 5Researchers develop ultra-simple method for creating nanoscale gold coatings 2MD Biosciences Offers Occlusion-induced Myocardial Infarct Model for Investigating the Cardio-protection of a Drug Treatment in the Event of Ischemia/reperfusion Injury 2
(Date:11/5/2014)... diversity in their ability to identify scents and odors. ... their perceptual evaluation of odors, with women outperforming men ... Sex differences in olfactory detection may play a role ... one,s perception of smell, which is naturally linked to ... been suggested to be cognitive or emotional, rather than ...
(Date:11/4/2014)... study examining only marketing directed at children on ... has found that the majority of black, middle-income ... marketing tactics. , Authored by Arizona State University ... is the first to examine the use of ... fast food restaurants and its relationship to demographics. ...
(Date:11/3/2014)... study published in this month,s Proceedings ... activity of a recently discovered communication molecule of the ... been known to limit inflammation and the current study ... inhibits the ability of the immune system to recognize ... underlies IL-37,s effect on the immune system now allows ...
Breaking Biology News(10 mins):The female nose always knows: Do women have more olfactory neurons? 2Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3PNAS: From HIV to cancer, IL-37 regulates immune system 2
... can do more than just make you feel hot, reports ... Chemistry ; the active chemical in peppers can directly induce ... Capsaicin is the chemical in chili peppers that ... sensory neurons, creating the heat sensation and subsequent reactions like ...
... of York have helped to reveal more about the way ... could help in the development of new treatments for serious ... studied the way a protein found on the surface of ... fibronectin. Their discovery is an important step in understanding how ...
... Dr. Eric Lazartigues, Assistant Professor of Pharmacology at LSU ... been awarded a $1.2 million Research Project (RO1) grant ... the National Institutes of Health. The 5-year grant will ... role of the brain in regulating blood pressure and ...
Cached Biology News:LSUHSC's Lazartigues awarded $1.2 million grant 2